Company Filing History:
2 out of 1,287 
1 out of 26 
1 out of 3 Years Active: 2015-2017
Title: Yasuhiro Mochizuki: Innovator in Monoclonal Antibody Research
Introduction
Yasuhiro Mochizuki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, Mochizuki's work has the potential to impact medical diagnostics and treatment.
Latest Patents
Mochizuki's latest patents include a monoclonal antibody specifically recognizing asparagine synthetase. This invention aims to provide a tool for the quantitative analysis of asparagine synthetase in cells. The second patent focuses on a monoclonal antibody against human GPR87, which is crucial for diagnosing and treating malignant tumors. This antibody can recognize GPR87 expressed on cell membranes and is useful in biochemical analysis and immunohistological diagnosis of squamous cell carcinoma.
Career Highlights
Throughout his career, Yasuhiro Mochizuki has worked with esteemed institutions such as the University of Tokyo and Perseus Proteomics Inc. His research has been pivotal in advancing the understanding of monoclonal antibodies and their applications in medicine.
Collaborations
Mochizuki has collaborated with notable colleagues, including Takao Hamakubo and Hiroko Iwanari. These partnerships have further enriched his research and contributed to the success of his inventions.
Conclusion
Yasuhiro Mochizuki's innovative work in monoclonal antibody research showcases his dedication to advancing medical science. His patents hold promise for improving diagnostic and therapeutic strategies in oncology.